|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Interleukin-18:interleukin-10 ratio and in-hospital adverse events in patients with acute coronary syndrome显示文摘 | Chalikias G K Tziakas D N Kaski J C | 2005 | Atherosclerosis2005，182，1： | 1 |
| 2 | The effects of rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, on markers of endothelial cell activation, C-reactive protein, and fibrinogen levels in non-diabetic coronary artery disease patients显示文摘 | Sidhu JS Cowan D Kaski JC | 2003 | J Am Coll Cardiol2003，42，10： | 1 |
| 3 | The effects of rosiglitazone, a PPARgamma agonist, on markers of endothelial cell activation, C-reactive protein, and fibrinogen levels in non-diabetic coronary artery disease patients显示文摘 | Sidhu JS Cowen D Kaski JC | 2003 | J Am Coll Cardiol2003，42，10： | 1 |
| 4 | Effects of rosiglitazone on endothelial function in men with coronary artery disease without diabetes mellitus 显示文摘 | Sidhu JS Cowan D Kaski JC | 2004 | Am J Cardiol2004，94，2： | 1 |
| 5 | Effects of rosiglitazone on endothelial function in men with coronary artery disease without diabetes mellitus显示文摘 | Sidhu JS Cowan D Kaski JC | 2004 | American Journal of Cardiology2004，94，2： | 1 |
| 6 | The effects of rosiglitazone,a peroxisome proliferator-activated receptor-gamma agonist,on markers of endothelial cell activation,C-reactive protein,and fibrinogen levels in non-diabetic coronary artery diseage patents显示文摘 | Cowan D Kaski JC | 2003 | J Am Coll Cardiol2003，42，10： | 1 |
| 7 | Epicardial coronary artery tone and reactivity in patients with normal coronary arteriograms and reduced coronary flow reserve (syndrome X)显示文摘 | Kaski JC Tousoulis D Galassi AR | 1991 | J Am Coll Cardiol1991，18，1： | 1 |
| 8 | 显示文摘 | Dawn Kaski E J Strivastava D | 1992 | Science1992，225，： | 1 |
| 9 | Effects of rosiglitazone on endothelial function in men with coronary artery disease without diabetes mellitus 显示文摘 | Sidhu JS Cowan D Kaski JC | 2004 | Am J Cardiol2004，94，2： | 1 |
| 10 | Combining physical training with transcranial direct current stimulation to improve gait in Parkinson's disease: a pilot randomized controlled study 显示文摘 | Kaski D Dominguez R Allum J | 2014 | Clin Rehabil2014，28，11： | 1 |
| 11 | The effects of rosiglitazone, a PPARgamma agonist, on markers of endothelial cell activation, C-reactive protein, and fibrinogen levels in non-diabetic coronary artery disease patients显示文摘 | Sidhu JS Cowen D Kaski JC | 2003 | J Am Coll Cardiol2003，42，10： | 1 |
| 12 | Effects of rosiglitazone on endothelial function in men with coronary artery disease without diabetes mellitus 显示文摘 | Sidhu JS Cowan D Kaski JC | 2004 | Am J Cardiol2004，94，2： | 1 |
| 13 | The effects of rosiglitazone,a peroxisome proliferator-activated receptor-gamma agonist,on markers of endothelial cell activation,Creactive protein,and fibrinogen levels in non-diabetic coronary artery disease patients显示文摘 | COWAN D KASKI JC | 2003 | J Am Coll Cardiol2003，42，10： | 1 |
| 14 | Effects of rosiglitazone on endothelial function in men with coronary artery disease without diabetes mellitus显示文摘 | Sidhu JS Cowan D Kaski JC | 2004 | Am J Cardiol2004，94，2： | 1 |
| 15 | Inflammatory and anti inflammatory variable clusters and risk prediction in acute coronary syndrome patients:a factor analysis approach显示文摘 | TZIAKAS D N CHALIKIAS G K KASKI J C | 2007 | Atherosclerosis2007，193，： | 1 |
| 16 | A comparative study of bi- omarkers for risk prediction in acute coronary syn- drome-Results of the SIESTA(Systemic Inflammation Evaluation in non-ST-elevation Acute coronary syn- drome) study显示文摘 | KASKI J C FERNANDEZ-BERGIS D J CONSUE- GRA-SANCHEZ L | 2010 | Atherosclerosis2010，212，： | 1 |
| 17 | A comparative study of biomarkers for risk prediction in acute coronary syndrome-results of the SIESTA(aystemic inflammation evaluation in non-ST-elevation acute coronary syndrome)study显示文摘 | Kaski J C Fernández-Bergés D J Consuegra-Sánchez L | 2010 | Atherosclerosis2010，212，2： | 1 |
| 18 | Neuronal P/Q- type calcium channel dysfunction in inherited disorders of the CNS显示文摘 | RAJAKULENDRAN S KASKI D HANNA MG | 2012 | Nat Rev Neurol2012，8，2： | 1 |
| 19 | Interleukin-18:interleukin-10 ration and in hospital adverse events in patients with acute coronary syndrome显示文摘 | CHALIKIAS GK TZIAKAS D N KASKI J C | 2005 | Atherosclerosis2005，182，1： | 1 |
| 20 | Elevated serum neopterin levels and adverse cardiac events at 6 months follow-up in Mediterranean patients with non- ST segment elevation acute coronary syndrome显示文摘 | Kaski JC Consuegra-Sanchez L Femandez-Berges D J | 2008 | Atheroscle- rosis2008，201，1： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员